SR 11-7 · April 2011
N/A — predates generative AI deployment in banking.
OCC Bulletin 2026-13 · April 2026
The carve-out (Card ④) removes GenAI from the MRM citation framework but does not remove it from examination scope. Footnote 1's preserved unsafe/unsound carve-out, the agencies' general supervisory authorities, and consumer-protection regulations (ECOA, FCRA, UDAAP) continue to apply to GenAI deployments regardless of MRM scope.
Policy Significance
The practical examination posture for institutions deploying GenAI is now: no specific MRM standard to comply with, but full exposure to unsafe-or-unsound criticism, fair-lending review, and enterprise risk management standards. This is more, not less, ambiguous than SR 11-7 — institutions know what to do (something), but not what compliance looks like.
Three immediate operational implications: (1) Institutions deploying LLMs for credit analysis, BSA/AML screening, or customer-facing functions should expect examiner inquiry under general safety-and-soundness authority, framed around governance adequacy rather than specific MRM standards. (2) Consumer-protection intersections (adverse action notices generated by LLMs, GenAI used in marketing segmentation) likely require validation-like discipline under ECOA/Regulation B regardless of MRM citation authority. (3) Institutions should document their reliance on non-agency frameworks (NIST AI RMF 1.0, ISO/IEC 42001, internal AI governance) as the de facto control structure during the RFI window, both to demonstrate good-faith governance and to position themselves for the comment process.